143 related articles for article (PubMed ID: 38109777)
21. Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications.
Virtanen JO; Färkkilä M; Multanen J; Uotila L; Jääskeläinen AJ; Vaheri A; Koskiniemi M
J Neurovirol; 2007 Aug; 13(4):347-52. PubMed ID: 17849318
[TBL] [Abstract][Full Text] [Related]
22. Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation.
Komaroff AL; Pellett PE; Jacobson S
Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33177186
[TBL] [Abstract][Full Text] [Related]
23. Human herpes virus 6 and multiple sclerosis.
Moore FG; Wolfson C
Acta Neurol Scand; 2002 Aug; 106(2):63-83. PubMed ID: 12100366
[TBL] [Abstract][Full Text] [Related]
24. HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6.
Engdahl E; Gustafsson R; Ramanujam R; Sundqvist E; Olsson T; Hillert J; Alfredsson L; Kockum I; Fogdell-Hahn A
Hum Immunol; 2014 Jun; 75(6):524-30. PubMed ID: 24662416
[TBL] [Abstract][Full Text] [Related]
25. A human herpesvirus 6A-encoded microRNA: role in viral lytic replication.
Nukui M; Mori Y; Murphy EA
J Virol; 2015 Mar; 89(5):2615-27. PubMed ID: 25520507
[TBL] [Abstract][Full Text] [Related]
26. A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients.
Ongrádi J; Rajda C; Maródi CL; Csiszár A; Vecsei L
J Neurovirol; 1999 Oct; 5(5):529-32. PubMed ID: 10568890
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis.
Biström M; Jons D; Engdahl E; Gustafsson R; Huang J; Brenner N; Butt J; Alonso-Magdalena L; Gunnarsson M; Vrethem M; Bender N; Waterboer T; Granåsen G; Olsson T; Kockum I; Andersen O; Fogdell-Hahn A; Sundström P
Eur J Neurol; 2021 Feb; 28(2):579-586. PubMed ID: 33065762
[TBL] [Abstract][Full Text] [Related]
28. HHV-6 infection in multiple sclerosis. A clinical and laboratory analysis.
Pietiläinen J; Virtanen JO; Uotila L; Salonen O; Koskiniemi M; Färkkilä M
Eur J Neurol; 2010 Mar; 17(3):506-9. PubMed ID: 19566903
[TBL] [Abstract][Full Text] [Related]
29. Coinfection of human herpesviruses 6A (HHV-6A) and HHV-6B as demonstrated by novel digital droplet PCR assay.
Leibovitch EC; Brunetto GS; Caruso B; Fenton K; Ohayon J; Reich DS; Jacobson S
PLoS One; 2014; 9(3):e92328. PubMed ID: 24663487
[TBL] [Abstract][Full Text] [Related]
30. Infrequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from multiple sclerosis patients.
Mayne M; Krishnan J; Metz L; Nath A; Auty A; Sahai BM; Power C
Ann Neurol; 1998 Sep; 44(3):391-4. PubMed ID: 9749608
[TBL] [Abstract][Full Text] [Related]
31. Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9.
Reynaud JM; Jégou JF; Welsch JC; Horvat B
J Virol; 2014 May; 88(10):5421-36. PubMed ID: 24574405
[TBL] [Abstract][Full Text] [Related]
32. An encephalitic episode in a multiple sclerosis patient with human herpesvirus 6 latent infection.
Merelli E; Sola P; Barozzi P; Torelli G
J Neurol Sci; 1996 Apr; 137(1):42-6. PubMed ID: 9120486
[TBL] [Abstract][Full Text] [Related]
33. Human Herpesvirus 6A Tegument Protein U14 Induces NF-κB Signaling by Interacting with p65.
Aktar S; Arii J; Tjan LH; Nishimura M; Mori Y
J Virol; 2021 Nov; 95(23):e0126921. PubMed ID: 34549982
[TBL] [Abstract][Full Text] [Related]
34. High antibody levels against human herpesvirus-6A interact with lifestyle factors in multiple sclerosis development.
Wu J; Engdahl E; Gustafsson R; Fogdell-Hahn A; Waterboer T; Hillert J; Olsson T; Alfredsson L; Hedström AK
Mult Scler; 2022 Mar; 28(3):383-392. PubMed ID: 34124961
[TBL] [Abstract][Full Text] [Related]
35. Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis.
Behzad-Behbahani A; Mikaeili MH; Entezam M; Mojiri A; Pour GY; Arasteh MM; Rahsaz M; Banihashemi M; Khadang B; Moaddeb A; Nematollahi Z; Azarpira N
J Microbiol Immunol Infect; 2011 Aug; 44(4):247-51. PubMed ID: 21524958
[TBL] [Abstract][Full Text] [Related]
36. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis.
Meier UC; Cipian RC; Karimi A; Ramasamy R; Middeldorp JM
Front Immunol; 2021; 12():757302. PubMed ID: 34790199
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous presence of endogenous retrovirus and herpes virus antigens has profound effect on cell-mediated immune responses: implications for multiple sclerosis.
Brudek T; Christensen T; Hansen HJ; Bobecka J; Møller-Larsen A
AIDS Res Hum Retroviruses; 2004 Apr; 20(4):415-23. PubMed ID: 15157360
[TBL] [Abstract][Full Text] [Related]
38. [Establishment and clinical application of a new real time PCR assay for simultaneous detection of human herpesvirus-6A and human herpesvirus-6B].
Cai MT; Wu YD; Wu XJ; Shang SQ
Zhonghua Er Ke Za Zhi; 2009 Jul; 47(7):527-31. PubMed ID: 19951517
[TBL] [Abstract][Full Text] [Related]
39. Human herpesvirus 6 infection as a trigger of multiple sclerosis.
Voumvourakis KI; Kitsos DK; Tsiodras S; Petrikkos G; Stamboulis E
Mayo Clin Proc; 2010 Nov; 85(11):1023-30. PubMed ID: 20926836
[TBL] [Abstract][Full Text] [Related]
40. Anti-human herpesvirus 6A/B IgG correlates with relapses and progression in multiple sclerosis.
Ortega-Madueño I; Garcia-Montojo M; Dominguez-Mozo MI; Garcia-Martinez A; Arias-Leal AM; Casanova I; Arroyo R; Alvarez-Lafuente R
PLoS One; 2014; 9(8):e104836. PubMed ID: 25110949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]